Media & Impact
Published analysis, legislative testimony, and industry conversations.
Cannabis Wise Guys contributes operational intelligence to policy debates, market analysis, and industry education. Our policy contributions are grounded in commercial-scale operational experience—we testify on market structure because we’ve lived the consequences of bad regulations in the grow room.
Our experience working with facilities across multiple adult-use markets has informed our analysis on everything from licensing frameworks to compliance feasibility, giving us a unique perspective that bridges regulatory theory with cultivation reality.
Our work has informed state legislatures, shaped regulatory discourse, and provided reality checks for operators navigating the Green Fault Line between capital, compliance, and cultivation.
Published Analysis
Articles written by Max Jackson.
Cardinal News · March 25, 2026 · Co-authored with Chelsea Higgs Wise
Cannabis Advocates: Why Virginia Cannabis Retail Must Wait for Virginia Cannabis Supply (Op-Ed)
Grounding Virginia’s January 1, 2027 retail launch in biological production timelines, this piece demonstrates that the state’s five existing pharmaceutical processors are the only entities with flower currently curing in storage — independent cultivators, still facing facility buildout, permitting, and a minimum six-month seed-to-sale cycle, will have barely broken ground by launch day. Uses New Jersey as the definitive supply-side cautionary case: 552 cultivation licenses issued since April 2022, 46 operational — 8.3%, almost four years in — with the state forced to suspend licenses after discovering “inversion,” licensed businesses sourcing illicit cannabis to fill empty shelves. Argues that premature retail authorization without verified supply invites the same illicit market penetration, destabilizes medical operations serving existing patients, and forfeits the stable tax revenue that depends on market integrity. Extends the “Ready Together” framework proposed in the Richmond Times-Dispatch: retail authorization in each Health Service Area triggers only when independent cultivators and retailers demonstrate operational readiness — not when a calendar date arrives.
Richmond Times-Dispatch · March 2026 · Co-authored with Chelsea Higgs Wise
Virginia Has More Data Than Any Governor Has Ever Had at a Cannabis Launch. The Question Is Whether It Gets Used. (Op-Ed)
Citing Headset point-of-sale data across 15 adult-use states, this piece demonstrates that competitive market structure — not tax rates, not licensing fees — is the primary determinant of cannabis revenue per capita. Massachusetts generates $212 per capita across 491 brands; Ohio generates $95 across 178, with its AG now litigating antitrust charges against nine companies — five of whom hold Virginia licenses. Uses Illinois’ state-commissioned disparity study as the definitive cautionary case: three license categories created specifically for independent businesses generated zero revenue during the period when converted medical operators had uncontested market access. Proposes a “Ready Together” framework giving Governor Spanberger executive authority to tie adult-use launch in each Health Service Area to verified independent competition — not an arbitrary calendar date.
Marijuana Moment · March 18, 2026
Virginia’s Cannabis Sales Legalization Bill Gives An Unfair Head Start To Existing Big Businesses (Op-Ed)
Using the framework of a three-phase market sequence, this piece makes the case that Virginia’s January 1, 2027 launch date isn’t just aggressive — it’s structurally determinative. Phase One (incumbents only), Phase Two (retailers with no independent supply), and Phase Three (independents merging onto a market already at full speed) demonstrate how sequencing — not licensing rules, not grant programs, not equity provisions — is the variable that produced concentrated markets in every comparable state. Proposes a regional market-readiness trigger: adult-use sales begin locally only when at least one independent cultivator and one independent retailer with no ties to existing processors are certified and selling.
Beard Bros Pharms · February 18, 2026
Ohio AG Yost Calls Them a “Cartel.” This Memoir Shows Why.
Analysis of Ohio AG Dave Yost’s landmark antitrust lawsuit against nine major MSOs—including Green Thumb Industries, Curaleaf, and Trulieve—accused of forming a cartel to fix prices and lock independent operators out of dispensary shelves. Using Adam Bierman’s memoir Weed Empire as primary evidence, the piece documents meetings, executives, and the “merit-based oligopoly” strategy Ohio is now prosecuting as antitrust violations. Argues the lawsuit creates precedent that could reshape how Virginia, Pennsylvania, and New Hampshire design their adult-use frameworks.
Marijuana Moment · February 16, 2026
Pennsylvania’s Cannabis Gamble: Why Over-Taxation Kills Revenue (Op-Ed)
Analysis of Governor Shapiro’s $729 million first-year cannabis revenue projection, arguing it only materializes if Pennsylvania avoids the tax-stacking failures that undermined California and Michigan. Using Michigan’s live experiment (a 24% wholesale tax increase effective January 2026 already threatening operator closures) and California’s repealed cultivation tax as case studies, the piece demonstrates how over-taxation drives consumers back to illicit markets and border-state dispensaries.
Beard Bros Pharms · February 3, 2026
The Schedule III Trap: The Monopoly Risk Nobody’s Watching
Analysis warning that Schedule III rescheduling risks codifying Metrc’s 24-state tracking monopoly into federal law. Explains why cannabis requires more surveillance than fentanyl, citing Missouri court rulings on illegal profit extraction, California court findings that the $100M system doesn’t work, and Maine ethics investigations. Proposes anti-monopoly language for federal implementation.
Cardinal News · January 15, 2026
Virginia’s $20 Million Cannabis Conversion Fee Isn’t Punitive — It’s Market Reality (Op-Ed)
Analysis using recent nine-figure acquisitions (Verano’s $90M purchase, Millstreet’s $160M counteroffer) to demonstrate that Virginia’s proposed $20 million conversion fee reflects actual market valuations for guaranteed adult-use entry, not political punishment. Co-authored with Marijuana Justice’s Chelsea Higgs Wise.
Marijuana Moment · December 10, 2025
Virginia Rejected a Monopoly Model for Marijuana, But Lawmakers Need to Finish the Job (Op-Ed)
Analysis of Virginia’s proposed cannabis framework arguing that strong policy intent will fail without operational guardrails. Breaks down three structural threats: the $10 million pharmaceutical processor conversion fee, the 120-day launch window (mathematically impossible for new cultivators to complete a crop cycle), and missing enforcement mechanisms for seed-to-sale tracking. Proposes “Market Readiness” benchmarks that tie retail launch to competitive supply, not arbitrary calendar dates.
Marijuana Moment · November 10, 2025
Hemp Needs What Alcohol Already Has: A Clear Definition (Op-Ed)
An op-ed analyzing the federal hemp standoff and proposing a framework to separate wellness products from intoxicating cannabis—demonstrating how operational understanding informs better policy design.
RVA Magazine · October 16, 2025
So You Want a Virginia Cannabis License? Read This First.
An operator’s playbook for prospective Virginia cannabis licensees. Outlines the strategic, legal, and financial preparations necessary to navigate a market shaped by regulatory capture and incumbent pressure, offering a reality check on everything from budgeting and facility design to the punishing impact of IRS §280E.
University Press, Florida Atlantic University · October 10, 2014
Amendment 2 Forum: Is Medical Marijuana Legalization Good For Florida?
A photo-journalistic piece from the Florida Atlantic University paper covering a public forum on the 2014 Amendment 2 ballot initiative, which debated the legalization of medical marijuana in Florida.
Legislative Testimony
Direct testimony and presentations to regulatory and legislative bodies.
Virginia Cannabis Oversight Commission · October 6, 2025
Testimony on Market Architecture & Regulatory Capture
Max Jackson testified before the Virginia Cannabis Oversight Commission on the structural risks of limited-license market models and the proven benefits of competitive market design. Drawing evidence from multi-state failures (Illinois, Arizona, Connecticut, Florida), the analysis demonstrates how incumbent market capture leads to failed social equity programs, inflated consumer prices, and thriving illicit markets. The testimony proposes four evidence-based guardrails: phased market launch prioritizing new Virginia operators, strict canopy limits preventing license stacking, multi-year social equity lockups, and regular data-driven market reviews.
Educational Presentations & Speaking
Guest lectures and presentations on operational feasibility, market analysis, and cannabis industry fundamentals.
Stockton University · Guest Lecture
The 8-Question Reality Check for Cannabis Ventures
A presentation on how to evaluate cannabis ventures for operational and financial viability. Walks through eight critical diagnostic questions—from space allocation and construction budgets to staffing and contingency planning—that separate viable projects from speculative failures. Max Jackson connects each question to career opportunities in specialized roles: facility design, HVAC engineering, compliance, automation, data analysis, and project management.
Want the diagnostic framework behind this lecture? Download the 8-Question Reality Check →
Industry Coverage
News articles and features about Max Jackson and Cannabis Wise Guys.
29News (WVIR) · March 25, 2026
Cannabis Advocates Urge Spanberger to Delay Jan. 1 Start Date for Recreational Sales
Local television coverage of the growing push for Governor Spanberger to delay Virginia’s January 1, 2027 adult-use launch date. Quotes Max Jackson directly on the production timeline gap: “It tends to take about 18 to 36 months to get those facilities online for the other production side.” The segment walks viewers through the biological math — six months of cultivation plus additional months for processing and packaging — to show that only Virginia’s existing medical operators will have product on shelves at launch, while independent businesses will still be building out facilities. Frames the timeline as a structural barrier to market competition, not a licensing technicality — the same analysis CWG has published across Cardinal News, the Richmond Times-Dispatch, and Marijuana Moment throughout March 2026.
Richmond BizSense · March 17, 2026
Recreational Pot Market Passes GA, Awaits Spanberger’s Signature
Coverage of Virginia’s retail cannabis bill clearing the General Assembly and heading to Governor Spanberger’s desk for signature. Quotes Max Jackson directly on the structural timeline disadvantage facing independent operators: “It takes 18 to 36 months to produce retail-ready product. Medical operators converting to the adult-use market don’t face any of this time. They already have the facilities and brand recognition.” The piece notes the $10 million medical conversion fee, the January 1, 2027 launch date, and the 350-license retail cap — the exact market architecture CWG has analyzed across multiple publications since October 2025.
Virginia Business · February 19, 2026
Virginia Moves Closer to Legal Retail Marijuana Sales
Coverage of the Virginia General Assembly passing competing retail cannabis bills (House Bill 642 and Senate Bill 542), quoting Max Jackson on the structural risks of both the launch timeline and tax structure. Jackson’s commentary flags that independent licensees typically require 18–36 months from license to first crop cycle—meaning any launch date before mid-2027 effectively hands incumbents a market monopoly by default.
Virginia Mercury · October 7, 2025
Virginia Cannabis Panel Weighs Retail Roadmap Against Safety, Access and Equity Concerns
Coverage of the Joint Commission meeting, warning that giving medical incumbents a head start in the adult-use market leads to corporate capture, higher prices, and fails to displace the illicit market.
Marijuana Moment · October 7, 2025
Virginia Lawmakers Discuss Steps To Prepare State To Legalize Recreational Marijuana Sales Next Year
Summarizes the legislative commission meeting, highlighting testimony on avoiding market consolidation and arguing that Virginia should not give existing medical businesses an unfair advantage in the recreational market.
RVA Magazine · October 9, 2025
Who Benefits From Virginia’s Cannabis Chaos? Small Businesses Want Answers
An investigation into the coordinated legislative and enforcement pressures on Virginia’s small hemp businesses, covering testimony from the General Assembly session and questioning who stands to gain as the state moves toward a regulated adult-use market.
Industry Conversations
Podcasts and video conversations on the state of the industry.
Growcast
Scaling Up, Pest Pressure, and the State of the Cannabis Industry
A discussion on the realities of scaling from a home grow to a commercial operation. Max Jackson covers common pitfalls, the importance of planning and monitoring, and shares unfiltered stories about dealing with severe pest infestations and the challenges of navigating emerging markets, broken testing standards, and corporate interests.
Cannabis Accounting Podcast
Operational Reality Checks in Cannabis Cultivation
Max Jackson discusses the real-world operational challenges in cannabis cultivation, bridging the gap between plants and finance. Topics include infrastructure oversights, the critical need for Integrated Pest Management (IPM), the overlooked complexities of green waste disposal, and common pitfalls in budgeting for operational versus capital expenditures.
Karma Koala Podcast
Cannabis, Water Usage, and Challenging Regulations
A deep dive into the often-overlooked topics of water usage and irrigation in industrialized cannabis. Covers the challenges posed by inexperienced regulators, the inefficiencies of systems like Metrc, and the critical disconnect between investors and the on-the-ground realities of growing the plant.
Future Cannabis Project
Leveraging Metrc Data for Cannabis Cultivation Optimization
Max Jackson reveals how to transform mandatory Metrc data into a powerful tool for cultivation optimization—creating “heatmaps” to visualize plant performance, identify microclimate issues, and make informed decisions on irrigation and canopy management. The discussion also critically examines the cost and efficacy of Metrc and the industry’s shift toward data-driven, quality-focused cultivation.